Phreesia (PHR)
NYSE:PHR
Want to see PHR full AI Analyst Report?
PHR Stock Chart & Stats
$9.17
$0.87(3.22%)
At close: 4:00 PM EST
$9.17
$0.87(3.22%)
Day’s Range― - ―
52-Week Range$7.77 - $32.76
Previous CloseN/A
Volume173.69K
Average Volume (3M)1.58M
Market Cap
$609.47M
Enterprise Value$627.32M
Total Cash (Recent Filing)$74.71M
Total Debt (Recent Filing)$92.56M
Price to Earnings (P/E)47.3
Beta1.05
Next Earnings
Sep 09, 2026EPS Estimate
0.09Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.15
Shares Outstanding61,811,890
10 Day Avg. Volume2,176,403
30 Day Avg. Volume1,579,008
Financial Highlights & Ratios
PEG Ratio-3.35
Price to Book (P/B)2.38
Price to Sales (P/S)1.67
P/FCF Ratio11.85
Enterprise Value/Market Cap1.03
Enterprise Value/Revenue1.27
Enterprise Value/Gross Profit2.13
Enterprise Value/Ebitda14.81
Forecast
1Y Price Target
$14.33Price Target Upside56.31% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering18
EPS Forecast (FY)0.32
Revenue Forecast (FY)$515.67M
Bulls Say, Bears Say
Bulls Say
Strong Free Cash FlowPhreesia has converted recent profitability into durable cash generation, with TTM FCF of $76M and ~19% FCF growth. Strong cash conversion supports reinvestment, debt servicing, and acquisition integration flexibility, lowering liquidity risk across 2-6 months and beyond.
Profitability Inflection & EBITDA MarginA sustained move to positive EBITDA and maintained FY guidance reflect structural operating leverage from product mix and cost actions. Higher margins expand internal funding for growth initiatives and cushion against demand variability over the medium term.
Payments Scale & Financing CapacityPayment Solutions growth, amplified by Access One, plus a larger securitization facility increases capacity to fund receivables and scale payments volume. This enhances a recurring, fee-generating revenue stream and strengthens structurally supporting financing for that business.
Bears Say
Subscription Revenue SoftnessSubscription contracts are core recurring revenue and price/volume moderation reduces visibility and lifetime value. A sequential decline signals potential churn, pricing pressure or delayed upsells that could erode predictable revenue and margin stability over the coming quarters.
Network Solutions Visibility RiskHigher variability in Network Solutions commitments weakens revenue predictability and relies on brand-specific dynamics and regulatory factors. Reduced client spend and forecasting noise raise execution risk for planned revenue and margin targets later in the fiscal year.
Increased Credit & Guaranty ExposureAmending the receivables facility increases allowance for lower-rated provider exposure and makes Phreesia a joint guarantor, heightening contingent liability and credit concentration risk. Adverse receivable performance could strain liquidity or require incremental capital support.
Phreesia News
PHR FAQ
What was Phreesia’s price range in the past 12 months?
Phreesia lowest stock price was $7.77 and its highest was $32.76 in the past 12 months.
What is Phreesia’s market cap?
Phreesia’s market cap is $609.47M.
When is Phreesia’s upcoming earnings report date?
Phreesia’s upcoming earnings report date is Sep 09, 2026 which is in 101 days.
How were Phreesia’s earnings last quarter?
Phreesia released its earnings results on May 27, 2026. The company reported $0.05 earnings per share for the quarter, beating the consensus estimate of $0.011 by $0.039.
Is Phreesia overvalued?
According to Wall Street analysts Phreesia’s price is currently Undervalued.
Does Phreesia pay dividends?
Phreesia does not currently pay dividends.
What is Phreesia’s EPS estimate?
Phreesia’s EPS estimate is 0.09.
How many shares outstanding does Phreesia have?
Phreesia has 61,811,890 shares outstanding.
What happened to Phreesia’s price movement after its last earnings report?
Phreesia reported an EPS of $0.05 in its last earnings report, beating expectations of $0.011. Following the earnings report the stock price went up 3.505%.
Which hedge fund is a major shareholder of Phreesia?
Currently, no hedge funds are holding shares in PHR
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Phreesia Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$14.33 (56.31% Upside)
$14.33 (56.31% Upside)
Blogger Sentiment
Bullish
PHR Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 2.0M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $28.7M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▲ 0.6%
Last 30 Days ▼ 3.9%
Last 30 Days ▼ 3.9%
News Sentiment
Bullish
Bullish news 79%
Bearish news 19%
Bearish news 19%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-59.63%
12-Months-Change
Fundamentals
Return on Equity
3.87%
Trailing 12-Months
Asset Growth
66.37%
Trailing 12-Months
Company Description
Phreesia
Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. Its Phreesia Platform offers a suite of solutions to manage the patient intake process, as well as an integrated payments solution for processing of patient payments. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, which are self-service intake tablets; and Arrivals Kiosks that are on-site kiosks. Its Phreesia Platform also provides a registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, and cost estimation tools; access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking; and life sciences solution to deliver targeted and clinically relevant marketing content to patients. In addition, the company's Phreesia Platform offers clinical support solution, which collects clinical intake and patient reported outcome (PRO) data for approximately 25 specialties, as well as enables healthcare services clients to communicate with their patients through surveys, announcements, text and email messaging, and health campaigns; and COVID-19 support modules for managing COVID-19 vaccine delivery and identify vaccine-hesitant patients, screening for self-reported COVID-19 risk factors, enabling contactless check-in during in-person visits, and collecting intake information during telehealth visits. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was incorporated in 2005 and is headquartered in Raleigh, North Carolina.
PHR Company Deck
PHR Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presented multiple clear operating and financial positives: solid top-line growth (+13% YoY), strong adjusted EBITDA improvement (+~46% YoY) and a return to net income, improved operating and free cash flow, enhanced liquidity via refinancing and a larger securitization facility for Access One, and maintained full-year guidance. Headwinds included a sequential decline in subscription revenue, higher variability and lower-than-expected client commitments in Network Solutions for the back half of the year, and some dependence of Payment Solutions growth on the recent Access One acquisition. On balance, the positive operational and financial momentum, maintaining guidance, and strategic financing and product initiatives outweigh the listed challenges.View all PHR earnings summariesPHR Revenue Breakdown
45.91% Subscription and related services
27.90% Payment processing fees
26.19% Network solutions
PHR Stock 12 Month Forecast
Average Price Target
$14.33
▲(56.31% Upside)
Technical Analysis
Ownership Overview
20.45% Insiders
22.65% Mutual Funds
35.52% Other Institutional Investors
10.04% Public Companies and
Individual Investors